Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
52,223,325
-
Total 13F shares
-
4,006,054
-
Share change
-
+11,186
-
Total reported value
-
$10,017,522
-
Put/Call ratio
-
42%
-
Price per share
-
$2.50
-
Number of holders
-
28
-
Value change
-
-$427,839
-
Number of buys
-
8
-
Number of sells
-
19
Institutional Holders of DiaMedica Therapeutics Inc. - Common Shares, no par value (DMAC) as of Q1 2022
As of 31 Mar 2022,
DiaMedica Therapeutics Inc. - Common Shares, no par value (DMAC) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,006,054 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, COOPERMAN LEON G, VANGUARD GROUP INC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and BlackRock Inc..
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.